Shionogi applies for COVID-19 vaccine approval | Japanese pharmaceutical firm Shionogi & Co said Thursday it has applied to the health ministry for approval of its coronavirus vaccine. It has mar

Shionogi applies for COVID-19 vaccine approval

Shionogi applies for COVID-19 vaccine approval

  • By: japantoday.com
  • Views 4
0
Shared

Japanese journalist freed from Myanmar prison vows to tell story

Japan births at new low as population shrinks and ages

Tokyo students take oral English test in high school entrance exam

Japan reports 49,117 new coronavirus cases
Emperor discharged from hospital after tissue examination

Japanese pharmaceutical firm Shionogi & Co said Thursday it has applied to the health ministry for approval of its coronavirus vaccine.

It has marked the first application of a COVID-19 vaccine developed in Japan. Only two days after the ministry granted emergency approval for its coronavirus oral drug Xocova, the first for a domestic drugmaker, Shionogi is now seeking authorization to manufacture and sell the recombinant protein-based vaccine.

The Osaka-headquartered company said the vaccine it has asked the Ministry of Health, Labor and Welfare to approve is for use by adult COVID-19 patients in their first and third jabs.

The recombinant protein-based preventive vaccine is the same type as a COVID-19 vaccine developed by Novavax Inc and differs from messenger RNA vaccines developed by Pfizer Inc or Moderna Inc.

If approved, it may become an option for those who previously could not receive coronavirus vaccine shots due to allergies or other issues.

According to Shionogi, the new vaccine's clinical trial for booster shot administration showed that the level of neutralizing antibodies, which help to block virus infection, in patients was around the same as those who have received Pfizer vaccines.

In its clinical trial for their first shots, the neutralizing antibody titer was seen to be statistically much greater than those inoculated with AstraZeneca Plc. vaccine, Shionogi said.

Its other Japanese rivals, including Daiichi Sankyo Co and KM Biologics Co, have also been trying to develop coronavirus vaccines.




Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services Domain Authority 66 www.easybranches.com/contribute
brand-awarness

ads by Easy Branches

https://albeitinflame.com/q71qxv5kt2?key=fce98667b547cdec45c44114599b7d22